These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 7500041)

  • 41. Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients.
    Loke TK; Mallett KH; Ratoff J; O'Connor BJ; Ying S; Meng Q; Soh C; Lee TH; Corrigan CJ
    J Allergy Clin Immunol; 2006 Aug; 118(2):368-75. PubMed ID: 16890760
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.
    Irusen E; Matthews JG; Takahashi A; Barnes PJ; Chung KF; Adcock IM
    J Allergy Clin Immunol; 2002 Apr; 109(4):649-57. PubMed ID: 11941315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NFκB and glucocorticoid receptor activity in steroid resistance.
    Dawson C; Dhanda A; Conway-Campbell B; Dimambro A; Lightman S; Dayan C
    J Recept Signal Transduct Res; 2012 Feb; 32(1):29-35. PubMed ID: 22185489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
    Gougat C; Jaffuel D; Gagliardo R; Henriquet C; Bousquet J; Demoly P; Mathieu M
    J Mol Med (Berl); 2002 May; 80(5):309-18. PubMed ID: 12021843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The glucocorticoid receptor gene as a candidate for gene therapy in asthma.
    Mathieu M; Gougat C; Jaffuel D; Danielsen M; Godard P; Bousquet J; Demoly P
    Gene Ther; 1999 Feb; 6(2):245-52. PubMed ID: 10435109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids.
    Kam JC; Szefler SJ; Surs W; Sher ER; Leung DY
    J Immunol; 1993 Oct; 151(7):3460-6. PubMed ID: 8376786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation.
    Sousa AR; Lane SJ; Soh C; Lee TH
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):565-74. PubMed ID: 10482829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of glucocorticoid receptor signaling during inflammation.
    Smoak KA; Cidlowski JA
    Mech Ageing Dev; 2004; 125(10-11):697-706. PubMed ID: 15541765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucocorticoid-regulated transcription factors.
    Adcock IM
    Pulm Pharmacol Ther; 2001; 14(3):211-9. PubMed ID: 11448148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor-beta 1 increases glucocorticoid binding and signaling in macrophages through a Smad- and activated protein-1-mediated process.
    Peltier J; Perez J; Bellocq A; Escoubet B; Fouqueray B; Baud L
    Kidney Int; 2003 Jun; 63(6):2028-36. PubMed ID: 12753290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells.
    Cha HJ; Park MT; Chung HY; Kim ND; Sato H; Seiki M; Kim KW
    Oncogene; 1998 Feb; 16(6):771-8. PubMed ID: 9488041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Mechanism of action of glucocorticoids in asthma].
    Jaffuel D; Mathieu M; Godard P; Michel FB; Demoly P
    Rev Mal Respir; 1999 Sep; 16(4):431-42. PubMed ID: 10549054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B.
    Adcock IM
    Monaldi Arch Chest Dis; 1997 Apr; 52(2):178-86. PubMed ID: 9203818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mineralocorticoid Receptor (MR) trans-Activation of Inflammatory AP-1 Signaling: DEPENDENCE ON DNA SEQUENCE, MR CONFORMATION, AND AP-1 FAMILY MEMBER EXPRESSION.
    Dougherty EJ; Elinoff JM; Ferreyra GA; Hou A; Cai R; Sun J; Blaine KP; Wang S; Danner RL
    J Biol Chem; 2016 Nov; 291(45):23628-23644. PubMed ID: 27650495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic stimulation of avian I kappa B alpha transcription by rel and fos/jun factors.
    Kralova J; Schatzle JD; Liss AS; Bargmann W; Bose HR
    Oncogene; 1996 Jun; 12(12):2595-604. PubMed ID: 8700518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppression of NF-kappa B and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: molecular mechanisms of anti-nephritic action.
    Sakurai H; Shigemori N; Hisada Y; Ishizuka T; Kawashima K; Sugita T
    Biochim Biophys Acta; 1997 Dec; 1362(2-3):252-62. PubMed ID: 9540856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucocorticosteroids.
    Barnes PJ
    Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts.
    Zhou F; Thompson EB
    Mol Endocrinol; 1996 Mar; 10(3):306-16. PubMed ID: 8833659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis.
    Tao Y; Williams-Skipp C; Scheinman RI
    J Biol Chem; 2001 Jan; 276(4):2329-32. PubMed ID: 11106637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.